Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. Click here to read more.

Acumatica has announced the general availability of its 2025 R2 ERP Platform. The R2 release features new and updated enhancements that improve usability, ...

Former New York Representative George Santos speaks to reporters outside of the Manhattan federal courthouse on April 18, 2024 after an initial conference in his copyright suit against Jimmy Kimmel ...

Our annual healthcare roundtable sizes up the risks and opportunities as public policy shifts. 16 stocks to buy now.

Find the best ChatGPT alternatives in 2025. Compare Perplexity AI, Claude, Gemini, Abacus.ai, and Copilot for research, ...

Some of the most common ways to tell if something was written using AI are: Key terms from your assignment prompt are used repeatedly. Inaccurate facts are included, thanks to the AI chatbot ...

Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release third quarter 2025 financial results before the market opens on Monday, ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline setbacks. In August 2025, Vertex’s phase II study on the oral formulation of ...

Gabriel Martinelli has struggled for form in recent months for Arsenal Arsenal return to Premier League action this weekend with the visit of Ange Postecoglou's Nottingham Forest - their first league ...